The identity and combination of regulators which signal myeloid cells to either self-renew or mature, have not been clearly separated. The delineation and biochemical characterization of factor(s) which regulate these processes would help define the physiologic problem in leukemia, which is thought to result from an uncoupling of gene expression that governs cellular proliferation and differentiation. In this research project, it is proposed (1) to purify a human active granulocyte-macrophage/leukemia differentiation-inducing protein (GM-DF), (2) to define its relationship to species of colony stimulating factor (CSF), (3) to delineate the mechanisms of action by which GM-DF affects cell differentiation and (4) to determine its potential therapeutic application, by studying its in vitro target cell specificity and mechanism of action and its in vivo ability to inhibit leukemia. The following experimental techniques and design will be applied: (1) Biochemical purification with ammonium sulfate precipitation, Anion Exchange chromatography, Gel filtration, Affinity chromatography including Porcion Red Agarose, AH Sepharose, Controlled Glass Pore Bead, and Hydroxyapatite Isoelectric focusing and Waters Reverse phase High Pressure Liquid Chromatography. Fractions obtained at each point will be assayed for (a) GM-DF in agar cultures containing WEHI-3B(D+) or HL-60 cells, scored day 7 and 14 respectively for total and diffuse (differentiated) colonies; and (b) CSF, in the day 7 CFU-GM clonogenic assay in soft agar. (2) Purified GM-DF and partially purified preparations free of CSF, will be utilized in studies employing both fresh and cell line derived leukemic cells in suspension and agar cultures, in order to determine the target cell specificity for differentiation induction, kinetics and S phase specificity of GM-DF cell maturation promotion. Experiments employing GM-DF as anti-leukemic maturation therapy in syngeneic transplantable myelomonocytic leukemia, will be tested. Finally, while purification of GM-DF is awaited, it is planned to study the induction of GM-DF by Novo-Pyrexal (a highly purified preparation of endotoxin, derived from S. abortus equi.) in man, and in particular in patients with Acute Myelogenous Leukemia (ANLL) all FAB classifications, Chronic Myelogenous Leukemia (CML) in accelerated phase or in blast crisis, and Preleukemia or Myelodysplastic syndrome (MDS).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08CA000966-02
Application #
3079431
Study Section
(SRC)
Project Start
1984-08-01
Project End
1987-07-31
Budget Start
1985-08-01
Budget End
1986-07-31
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Campagnaro, Erica; Saliba, Rima; Giralt, Sergio et al. (2008) Symptom burden after autologous stem cell transplantation for multiple myeloma. Cancer 112:1617-24
Donigian, Jill R; de Lange, Titia (2007) The role of the poly(ADP-ribose) polymerase tankyrase1 in telomere length control by the TRF1 component of the shelterin complex. J Biol Chem 282:22662-7
Gabrilove, J L; Jakubowski, A; Scher, H et al. (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414-22
Starnes Jr, H F; Warren, R S; Jeevanandam, M et al. (1988) Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 82:1321-5
Gabrilove, J L; Jakubowski, A; Fain, K et al. (1988) Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 82:1454-61
Krown, S E; Mintzer, D; Cunningham-Rundles, S et al. (1987) High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses. Cancer Treat Rep 71:39-45
Moore, M A; Welte, K; Gabrilove, J et al. (1987) Biological activities of recombinant human granulocyte colony stimulating factor (rhG-CSF) and tumor necrosis factor: in vivo and in vitro analysis. Haematol Blood Transfus 31:210-20
Gabrilove, J L; Welte, K; Harris, P et al. (1986) Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637. Proc Natl Acad Sci U S A 83:2478-82
Gabrilove, J L (1986) Differentiation factors. Semin Oncol 13:228-33
Souza, L M; Boone, T C; Gabrilove, J et al. (1986) Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 232:61-5

Showing the most recent 10 out of 11 publications